Happy Thanksgiving from Laviana Pharma Co., Ltd. We are deeply grateful for the trust and support of our Clients, Friends, Family, and Employees. Wishing you a season filled with joy, warmth, and cherished moments. Thank you for being part of our journey
LAVIANA PHARMA CO, LTD ’s Post
More Relevant Posts
-
The cost of going green: definitely underhyped! If you are keen to go green but not sure on how to navigate the cost challenges, why not have a chat with one of our sustainability experts at Argon & Co ? 🌿🌎
The cost of going green ♻️ was a hot topic on site at LogiPharma a couple of weeks ago, so we asked some of our supply chain leaders what they thought, and here's what they had to say: A massive thank you to our contributors 🎤 Iqbal Noormohamed at Glenmark Pharmaceuticals Bharath Sundararaman at TraceLink Daniela Vial at LATAM Cargo Ryan Portela at Worldwide Business Research (WBR) Jeff Tucker at Tucker Company Worldwide Shirell James at One Network Enterprises Esther Tichauer, MBio CSCP at Argon & Co So, what do you think about the cost of going green? Is it overhyped, underhyped or just plain hyped? Let us know in the comments! 👇
-
Hear what draws Genentech’s Kimberly Barnholt back to DPHARM every year! “What I really appreciate about DPHARM is feeling connected to the broader ecosystem and learning about not only what’s out there, but how we can bring it back into our daily work.” Learn more about DPHARM: DPHARMconference.com #DPHARM2024 #ClinicalTrials #ClinicalInnovation #ClinicalResearch
-
Reliable Machines with follow up AMCs
On the occasion of the 10th anniversary of the company, I would like to thank everyone who has directly or indirectly involved in the Success. We are excited about the opportunities ahead to extend our track record of Value creation, innovation and success in machine manufacturing in the food and pharma industry.
-
Making a meaningful impact and improving patient lives: That’s true fulfillment for us. For Lana, being a Product Manager in pharmaceuticals is more than just managing product lines; it’s about making a difference. Every day, she’s driven by a passion for connecting with patients, listening to their journeys, and understanding their needs. This connection fuels her work, ensuring that each product she manages is aligned with real-life impacts. Her role combines strategy and compassion, as she works to bring innovative, life-improving solutions to market, knowing they have the potential to change lives. Being a Product Manager at Sanofi means being on the frontline of healthcare innovation, bridging the gap between patient experiences and medical advancement. It's about ensuring that the work we do is not only effective but also deeply meaningful. 👩⚕️💊 Learn more about her journey: http://spkl.io/6040frApy #WeNeverSettle #IgnitingPotential #RareDisease Sanofi
-
According to research conducted by FoodNavigator, more than one-third of shoppers in North America prioritize purchasing products with the #NonGMO verification mark. Brands and businesses have a unique opportunity to respond and cater to the demands of consumers as they become more aware of safer food and beverage options. Read NSF's Non-GMO Project Verification Guide here ➡️ https://lnkd.in/e2XPPQMS.
FOOD NAVIGATOR USA recently reported on research showing the surge in consumer support for Non-GMO Project Verified products and emphasizing consumer awareness and preference for independent, third-party certification. Twice as many consumers say Non-GMO Project verification motivates them to buy that product over a product that does not carry a third-party certification or verification. NSF can help you get Non-GMO Project certified, prioritizing your brand in this ultra-competitive marketplace. Download NSF’s Non-GMO Project Verification Guide here. https://bit.ly/3CM1rhC
-
-
🔎Sanofi's plan to sell a 50% stake in its consumer health unit, Opella, to Clayton, Dubilier & Rice supports its focus on drug development. The French finance ministry backs the deal, highlighting the need to maintain operations in France. The estimated 15 billion euro sale reflects Opella's value, with a cautious market response. 📚 Sanofi in talks to sell 50% stake in consumer health business to CD&R. 🔗https://lnkd.in/emvbUMV7
-
First mover STADA 📍 Spain! In 2023, STADA made history as the first pharmaceutical company in Spain to join the Lean & Green program, a leading European initiative championing decarbonization in logistics. This milestone marks a significant step toward our environmental goals, including a 42% reduction in CO2 emissions by 2030. In November, we proudly received recognition at the Lean & Green Awards for our dedication to sustainable logistics. As part of our commitment, STADA España has pledged to cut carbon emissions from logistics operations by 20% in the next five years. We are thrilled to be the first pharmaceutical company in Spain to earn this honor, driving forward our mission for a greener future. Read more about Sustainability at STADA: https://lnkd.in/eB7scevz #ItComesNaturallyToUs #TakingResponsibility #Sustainability #ESG
-
You heard of a "Petrostate"? Now we have a "Pharmastate". What could possibly go wrong??? "Nearly 1 out of every 5 Danish jobs created last year was at Novo. And that's just directly. If you also include the jobs that Novo has created indirectly — like, for example, at its suppliers, or from all the newly wealthy Novo employees spending their money at shops and restaurants — nearly half of all private-sector nonfarm jobs created in Denmark can be traced back to Novo." https://lnkd.in/emZpKgPz
-
4 Key Takeaways From Eli Lilly’s Earnings
4 Key Takeaways From Eli Lilly’s Earnings
